Lachnospira is a signature of antihistamine efficacy in chronic spontaneous urticaria
- 24 September 2021
- journal article
- research article
- Published by Wiley in Experimental Dermatology
- Vol. 31 (2) , 242-247
Abstract
Chronic spontaneous urticaria (CSU) is a mast cell‐driven disease with many advances in its aetiology and pathogenesis over the past years. The main treatment of CSU is oral second‐generation antihistamines. However, only an average of 50% of CSU patients responded adequately to conventional or quadruple doses of non‐sedative antihistamines. Meanwhile, gut microbiota can affect the efficacy of drugs. The purpose of this study was to investigate the relationship between gut microbiota and the efficacy of antihistamines in patients with CSU. The patients with CSU were divided into responders and non‐responders according to the efficacy of antihistamine monotherapy. The gut microbiota of faecal samples from 15 responders and 15 non‐responders was detected by 16S rDNA sequencing, and the differential bacterial species between the two groups were verified by quantitative polymerase chain reaction (qPCR). Additional faecal samples from 30 responders and 30 non‐responders were used as an extended cohort to further verify the above differential bacterial species by qPCR. Lachnospiraceae and its subordinate taxa were found to be the main differences in gut microbiota between responders and non‐responders. The abundance of Lachnospira in responders was higher than that in non‐responders. Lachnospira exhibits moderate diagnostic value in evaluating the efficacy of antihistamine. Lachnospira is a signature for predicting the efficacy of antihistamine in patients with CSU.Keywords
Funding Information
- National Natural Science Foundation of China (81974476, 81773341, 81830096, 81673065)
This publication has 21 references indexed in Scilit:
- Evaluation of a Guidelines-Based Approach to the Treatment of Chronic Spontaneous UrticariaThe Journal of Allergy and Clinical Immunology: In Practice, 2018
- Association of ORAI1 gene polymorphisms with chronic spontaneous urticaria and the efficacy of the nonsedating H1 antihistamine desloratadineJournal of Allergy and Clinical Immunology, 2017
- Sedative Effects of Levocetirizine: A Systematic Review and Meta-Analysis of Randomized Controlled StudiesDrugs, 2017
- Cost Utility of Omalizumab Compared with Standard of Care for the Treatment of Chronic Spontaneous UrticariaPharmacoEconomics, 2016
- Resource Use and Costs in an Insured Population of Patients with Chronic Idiopathic/Spontaneous UrticariaAmerican Journal of Clinical Dermatology, 2015
- The potential pharmacologic mechanisms of omalizumab in patients with chronic spontaneous urticariaJournal of Allergy and Clinical Immunology, 2015
- On the Colonic Bacterial Metabolism of Azo-Bonded Prodrugsof 5-Aminosalicylic AcidJournal of Pharmaceutical Sciences, 2014
- Does terfenadine‐induced ventricular tachycardia/fibrillation directly relate to its QT prolongation and Torsades de Pointes?British Journal of Pharmacology, 2012
- Pharmacological rationale for the treatment of chronic urticaria with second‐generation non‐sedating antihistamines at higher‐than‐standard dosesJournal of the European Academy of Dermatology and Venereology, 2011
- The impact of chronic urticaria on the quality of lifeBritish Journal of Dermatology, 1997